Home » Topics » Regulatory » Patents

Patents
RSS

Kv1 potassium channel inhibitors with anxiolytic properties synthesized at Lectus Therapeutics

Feb. 2, 2009

New renin inhibitors disclosed in joint patent from GSK and Vitae

Feb. 2, 2009

Novel protein kinase inhibitors manufactured at Abbott

Jan. 30, 2009

Roche divulges antipsychotic tachykinin NK3 receptor antagonists

Jan. 30, 2009

New cathepsin K inhibitors developed at AstraZeneca

Jan. 30, 2009

Argenta and AstraZeneca jointly impart novel muscarinic M3 receptor antagonists

Jan. 30, 2009

Histamine H3 receptor modulators for treating obesity developed at Roche

Jan. 30, 2009

Kyowa Hakko Kirin describes novel antitumor agents

Jan. 29, 2009

New chemokine CXCR5 receptor antagonists prepared and tested at sanofi-aventis

Jan. 29, 2009

Roche claims novel PI3K inhibitors with potential as anticancer agents

Jan. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.